Serreze D V, Leiter E H, Shultz L D
Jackson Laboratory, Bar Harbor, Maine.
Diabetologia. 1990 Feb;33(2):84-92. doi: 10.1007/BF00401045.
F1 hybrids produced by outcross of non-obese diabetic (NOD) mice with diabetes resistant strains are also diabetes resistant. This resistance is abrogated if F1 hybrids are lethally irradiated and then haematopoietically reconstituted with NOD bone marrow. This model was employed to determine whether T lymphocyte recognition and elimination of pancreatic B cells in NOD mice is restricted by the MHC haplotype of the target B cell. Diabetes resistant (NOD/Lt x CBA/J)F1 hybrids were lethally irradiated and reconstituted with NOD/Lt bone marrow. Following haematopoietic reconstitution, donor matched NOD/Lt or CBA/J pancreatic islet and anterior pituitary grafts were grafted under a renal capsule to determine whether effector cells derived from NOD/Lt marrow progenitors would reject islet grafts in a MHC restricted fashion. The H-2k haplotype expressed by CBA/J mice differs from all known loci of the unique H-2 haplotype of NOD; therefore, if NOD/Lt T lymphocytes eliminate pancreatic B cells in a MHC restricted fashion. NOD islet grafts would be eliminated in these chimeras while CBA islet grafts would be retained. Overt diabetes developed in 80% of the female and 40% of the male F1 hybrids following reconstitution with NOD/Lt marrow, while no hybrids reconstituted with CBA/J marrow became diabetic through a year of age. The retention of CBA/J skin and pituitary grafts in NOD/Lt marrow reconstituted F1 hybrids confirmed that the F1 thymic environment imparted tolerance to CBA/J alloantigens. Nonetheless, responses to a T cell dependent model antigen were restricted to the unique MHC haplotype of NOD. This was associated in the hyperglycaemic chimeras with rejection (8-21 days post-implantation) of both CBA/J and NOD/Lt islet grafts.(ABSTRACT TRUNCATED AT 250 WORDS)
将非肥胖糖尿病(NOD)小鼠与糖尿病抗性品系杂交产生的F1代杂种同样具有糖尿病抗性。如果对F1代杂种进行致死性照射,然后用NOD骨髓进行造血重建,这种抗性就会消失。利用该模型来确定NOD小鼠中T淋巴细胞对胰腺B细胞的识别和清除是否受靶B细胞的MHC单倍型限制。对具有糖尿病抗性的(NOD/Lt×CBA/J)F1代杂种进行致死性照射,并用NOD/Lt骨髓进行重建。造血重建后,将供体匹配的NOD/Lt或CBA/J胰岛及垂体前叶移植到肾被膜下,以确定源自NOD/Lt骨髓祖细胞的效应细胞是否会以MHC限制的方式排斥胰岛移植。CBA/J小鼠表达的H-2k单倍型不同于NOD独特H-2单倍型的所有已知基因座;因此,如果NOD/Lt T淋巴细胞以MHC限制的方式清除胰腺B细胞,这些嵌合体中的NOD胰岛移植将被清除,而CBA胰岛移植将被保留。用NOD/Lt骨髓重建后,80%的雌性和40%的雄性F1代杂种出现明显糖尿病,而用CBA/J骨髓重建的杂种在一岁前均未患糖尿病。在NOD/Lt骨髓重建的F1代杂种中保留CBA/J皮肤和垂体移植,证实F1胸腺环境赋予了对CBA/J同种抗原的耐受性。尽管如此,对T细胞依赖性模型抗原的反应仅限于NOD独特的MHC单倍型。这与高血糖嵌合体中CBA/J和NOD/Lt胰岛移植的排斥反应(植入后8 - 21天)有关。(摘要截断于250字)